Ben Atkins
Geen lopende functies
Loopbaan van Ben Atkins
Eerdere bekende functies van Ben Atkins
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Investor Relations Contact | - | 02-03-2023 |
| Public Communications Contact | - | 02-03-2023 |
Opleiding van Ben Atkins
| King's College London | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Beurs
- Insiders
- Ben Atkins
- Ervaring
